Memorializing Governor Kathy Hochul to proclaim May 12, 2026, as Fibromyalgia Awareness Day in the State of New York
This resolution memorializes Governor Kathy Hochul to proclaim May 12, 2026, as Fibromyalgia Awareness Day in New York State. It is a commemorative measure rather than a regulatory or appropriations bill, and its text focuses on educating the public about fibromyalgia, describing the condition’s symptoms, prevalence, diagnostic delays, and the challenges patients face in obtaining treatment and recognition.
The resolution highlights fibromyalgia as a chronic syndrome associated with widespread pain, fatigue, sleep problems, cognitive difficulties, and other symptoms, and it emphasizes the lack of a known cause or cure. It also points to the need for better physician education, improved awareness in workplaces and schools, and broader support for patients and families affected by the illness. The measure directs that copies be sent to the Governor and several health and academic organizations, underscoring its awareness-raising and advocacy purpose.
Because this is a resolution, it does not amend the New York Consolidated Laws or create enforceable legal rights, duties, or funding obligations. Its practical effect is limited to urging the Governor to issue a proclamation and using the Legislature’s platform to recognize fibromyalgia and encourage public awareness, education, and support for affected individuals and advocacy groups.
The overall sentiment is strongly supportive and sympathetic toward people living with fibromyalgia. The resolution frames the condition as serious, underrecognized, and potentially disabling, and it expresses concern about delayed diagnosis, inadequate treatment, and social misunderstanding. No opposing views, votes, or committee objections are provided in the available record.
There is little visible contention in the bill text or available history because the measure is ceremonial and nonbinding. The only implied policy tension is around the adequacy of medical education, physician willingness to treat fibromyalgia patients, and the need for broader accommodations in employment, education, and health care; these concerns are presented from the perspective of patient advocates and the sponsoring resolution, not as formal opposition.